Matches in Nanopublications for { ?s ?p "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21039.RAtc9UVrY0LMeh8kNuk2cLttZGND-id5eylDlgn9jXwCk130_provenance.
- NP21042.RA326aYBmvawrbGgV7_tG4_LMJ001t3d3Ws3DKFL0z71g130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP21042.RA326aYBmvawrbGgV7_tG4_LMJ001t3d3Ws3DKFL0z71g130_provenance.
- NP20384.RAdgOdFNRBTun2eQPZlY_1mkNPkH2DVyUMl6NClQIPs-E130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20384.RAdgOdFNRBTun2eQPZlY_1mkNPkH2DVyUMl6NClQIPs-E130_provenance.
- NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20387.RAd5vah2DMbQuwYTH-L0cNd4wkKFni4uijHfg0XPDrVCg130_provenance.
- assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP19326.RAdeEPkTuOO0WTkttGZzdoHSamrTJPpa2AHgiDV6HoeLw130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19326.RAdeEPkTuOO0WTkttGZzdoHSamrTJPpa2AHgiDV6HoeLw130_provenance.
- NP19325.RANdOPgFioY_qbbpTUdlY1M6jDlyAz_eOja9s_No-VzAg130_assertion description "[Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19325.RANdOPgFioY_qbbpTUdlY1M6jDlyAz_eOja9s_No-VzAg130_provenance.